Company / Working Capital per Share
Sana Biotechnology, Inc. Working Capital per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.50
FY2024
5-year range
$0.50 / $27.13
FY2020-FY2024
Trend
-34.8%
vs FY2023
Sector context
#193 of 210
Health Care
What the data says
Among 210 Health Care companies, Sana Biotechnology, Inc. is in the bottom 8% for working capital per share. Working Capital per Share has declined for 4 consecutive years, from $27.13 in FY2020 to $0.50 in FY2024.
Based on SEC 10-K filings.
0.50 in FY2024 with a 3-year CAGR of -43.4%.
Declined from $1.77 to $0.50 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -43.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 210This company $0.50 Sector average $146.86
▼
-99.7% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s working capital per share has declined for 4 consecutive years.
- In FY2024, working capital per share decreased 34.8% year-over-year.
- Ranks #193 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.50 | -34.8% |
| FY2023 | $0.77 | -56.7% |
| FY2022 | $1.77 | -35.9% |
| FY2021 | $2.76 | -89.8% |
| FY2020 | $27.13 | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026